This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/526321-eu-approves-new-moderna-site-france/
The article has changed 3 times. There is an RSS feed of changes available.
Version 1 | Version 2 |
---|---|
EU drugs regulator approves new site for manufacture of Moderna Covid-19 vaccine in France | EU drugs regulator approves new site for manufacture of Moderna Covid-19 vaccine in France |
(about 1 month later) | |
The European Medicines Agency (EMA) has approved a new manufacturing plant in central France to boost production of the Moderna Covid-19 vaccine, the regulator’s committee for human medicines has said. | The European Medicines Agency (EMA) has approved a new manufacturing plant in central France to boost production of the Moderna Covid-19 vaccine, the regulator’s committee for human medicines has said. |
The new site will be in Monts near the Loire Valley town of Tours and will be operated by pharmaceutical manufacturer Recipharm, the EMA said in a statement on Friday. | The new site will be in Monts near the Loire Valley town of Tours and will be operated by pharmaceutical manufacturer Recipharm, the EMA said in a statement on Friday. |
The Sweden-headquartered firm already has a facility in Monts for the filling of pharmaceutical products into vials. | The Sweden-headquartered firm already has a facility in Monts for the filling of pharmaceutical products into vials. |
As well as a new manufacturing facility for the Moderna jab, the EMA said it has issued a “positive opinion” for alternative batch control and testing sites. | As well as a new manufacturing facility for the Moderna jab, the EMA said it has issued a “positive opinion” for alternative batch control and testing sites. |
Last week the regulator approved two new US sites for manufacturing the active substance and finished product of the US-developed Moderna jab. | Last week the regulator approved two new US sites for manufacturing the active substance and finished product of the US-developed Moderna jab. |
The EMA said it expects the approvals of the three sites to result in an extra 1 or 2 million vials of vaccine becoming available for the EU each month. | The EMA said it expects the approvals of the three sites to result in an extra 1 or 2 million vials of vaccine becoming available for the EU each month. |
In February the EU’s European Commission announced it had signed a deal with Moderna for an additional 150 million doses of its vaccine this year with the option to purchase another 150 million in 2022. | In February the EU’s European Commission announced it had signed a deal with Moderna for an additional 150 million doses of its vaccine this year with the option to purchase another 150 million in 2022. |
Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |